NCT04873128View on ClinicalTrials.gov

Comparative Genetic and Immune Response Analysis of Different COVID-19 Vaccine Candidates Using Multi-OMICS Approach

NARecruitingINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

June 10, 2021

Primary Completion Date

July 1, 2024

Study Completion Date

July 1, 2024

Conditions

Genetic Predisposition

Interventions

GENETIC

Multi-OMICS

Measurement of gene expression in immune cells (Human Peripheral Blood Mononuclear Cell (PBMCs) or total blood) using functional genomics, proteomics, metabolomics and lipidomics tools and compare the dynamics of immune response before and after vaccination against COVID-19.

Trial Locations (1)

72076

RECRUITING

University Hospital Tübingen, Tübingen

All Listed Sponsors

lead

University Hospital Tuebingen

OTHER